ThomasP.LoughranJr.MD
Oncology • Charlottesville, VAProfessor, Medicine,University of Virginia Director, University of Virginia Cancer Center
Dr. Loughran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1240 Lee St
Charlottesville, VA 22908Phone+1 434-924-9333Fax+1 434-243-6086
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1982 - 1985
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1979 - 1982
Drexel University College of MedicineClass of 1979
Certifications & Licensure
VA State Medical License 2013 - 2026
PA State Medical License 1980 - 2014
FL State Medical License 1996 - 2005- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Member of Board of Directors Association of American Cancer Institutes, 2018-2021
- First Annual Distinguished Alumni Lecture Thomas Jefferson University, 2011
- Ursinus College Alumni Award 2010
- Join now to see all
Clinical Trials
- Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia Start of enrollment: 2000 Aug 01
- Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia Start of enrollment: 2006 May 01
- Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome Start of enrollment: 2007 Apr 01
Publications & Presentations
PubMed
- 5 citationsEffective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia.Jonathan E Brammer, Karen Ballen, Lubomir Sokol, Christiane Querfeld, Ryotaro Nakamura
Blood. 2023-10-12 - 11 citationsTγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients.Gregorio Barilà, Angela Grassi, HeeJin Cheon, Antonella Teramo, Giulia Calabretto
Blood. 2023-03-02 - 1 citationsCancer Prevention from the Viewpoint of UVA Comprehensive Cancer Center.Thomas P Loughran, Wendy Cohn, Gloribel Bonilla, Roger T Anderson
Cancer Prevention Research. 2022-11-01
Other
- Natural killer (NK) cell large granular lymphocyte leukemiaLoughran TP, Lamy T
http://www.uptodate.com/contents/natural-killer-nk-cell-large-granular-lymphocyte-leukemia
UpToDate, Wolters Kluwer Health - 2012-09-10 - Treatment of large granular lymphocyte leukemiaLoughran TP, Lamy T
http://www.uptodate.com/contents/treatment-of-large-granular-lymphocyte-leukemia
UpToDate, Wolters Kluwer Health - 2012-03-30 - Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemiaLoughran TP, Lamy T
http://www.uptodate.com/contents/clinical-manifestations-pathologic-features-and-diagnosis-of-t-cell
UpToDate, Wolters Kluwer Health - 2012-11-26
Press Mentions
Providing HopeSeptember 30th, 2024- Top Docs 2021April 26th, 2021
Top Docs 2020April 27th, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
